Neurology Thesis Topics

Ø  An extensive collection of over 100,000 thesis topics is offered on the website, with approximately 10,000 topics per specialty, including a dedicated section for Neurology thesis topics.

Ø  Numerous medical journals have been meticulously reviewed to compile a list of recent Neurology thesis topics, ensuring resident doctors have access to the latest trends and developments within the field.

Ø  Through personalized WhatsApp guidance, support is provided to resident doctors throughout the thesis process across all broad specialties and super-specialties, including Neurology.

Ø  Thesis Protocol and Synopsis: Assistance is given in developing a well-structured protocol and synopsis specifically tailored for Neurology thesis topics.

Ø  Sample Size Determination: For studies on Neurology thesis topics, guidance is offered to determine the correct sample size using complex formulas and pilot studies, ensuring methodological precision.

Ø  Review of Literature: Comprehensive support is available for conducting a thorough literature review, establishing a strong foundation for Neurology thesis topics.

Ø  Statistical Methods: Advice is provided on selecting and applying the most appropriate statistical methods to meet the objectives of Neurology thesis topics.

 

Ø  This platform consolidates both conventional and new Neurology thesis topics, saving residents time and offering a streamlined research process.

NEUROLOGY THESIS TOPICS

Neurology Thesis Topics

  1. Comparative study on outcomes of endovascular thrombectomy versus intravenous thrombolysis in acute ischemic stroke
  2. Prospective analysis of recurrent stroke risk in cryptogenic versus non-cryptogenic ischemic stroke patients
  3. Efficacy of telemedicine in improving outcomes and reducing delay in acute stroke treatment
  4. Comparative study on cognitive outcomes in ischemic stroke patients with early versus delayed rehabilitation
  5. Role of genetic markers in predicting hemorrhagic transformation after ischemic stroke
  6. Comparative effectiveness of levetiracetam versus phenytoin in preventing seizures after stroke
  7. Prospective study on the impact of atrial fibrillation management on stroke prevention in elderly patients
  8. Outcomes of ketogenic diet versus anti-epileptic drugs in managing drug-resistant epilepsy in children
  9. Comparative study on the effectiveness of vagus nerve stimulation versus resective surgery in refractory epilepsy
  10. Evaluation of quality of life outcomes in epilepsy patients treated with CBD oil versus standard antiepileptic drugs
  11. Prospective study on neuroimaging biomarkers in predicting cognitive decline in Alzheimer’s disease
  12. Comparative outcomes of immunotherapy versus supportive care in patients with rapidly progressive dementia
  13. Long-term outcomes of amyloid-targeting versus tau-targeting therapies in mild cognitive impairment
  14. Role of genetic testing in early diagnosis and management of familial Alzheimer’s disease
  15. Comparative study on outcomes of oral versus intravenous immune-modulating therapies in multiple sclerosis
  16. Efficacy of rituximab versus corticosteroids in neuromyelitis optica spectrum disorders
  17. Comparative analysis of myasthenia gravis patients receiving plasmapheresis versus IVIG for acute exacerbations
  18. Prospective study on the effects of physical therapy versus occupational therapy in multiple sclerosis patients
  19. Efficacy of botulinum toxin versus occipital nerve block in managing chronic migraine
  20. Comparative outcomes of cognitive behavioral therapy versus medication in chronic tension-type headache
  21. Role of genetic polymorphisms in susceptibility to cluster headaches
  22. Comparative study on outcomes of biologics versus corticosteroids in treating giant cell arteritis with cranial involvement
  23. Efficacy of early versus delayed treatment in patients with optic neuritis for visual outcomes
  24. Prospective study on long-term cognitive outcomes in pediatric patients with autoimmune encephalitis
  25. Role of genetic counseling in families with a history of Huntington’s disease
  26. Comparative outcomes of deep brain stimulation versus medication in advanced Parkinson’s disease
  27. Evaluation of pharmacogenetic testing in predicting drug efficacy in Parkinson’s disease
  28. Prospective study on the impact of gene therapy in spinal muscular atrophy on neuromuscular function
  29. Comparative study on outcomes of rituximab versus methotrexate in managing progressive multifocal leukoencephalopathy
  30. Efficacy of noninvasive ventilation versus supportive care in amyotrophic lateral sclerosis
  31. Long-term outcomes of genetic testing in early diagnosis of Duchenne muscular dystrophy
  32. Comparative analysis of different immunotherapies in Guillain-Barré syndrome management
  33. Prospective study on sleep disturbances in myasthenia gravis and their impact on quality of life
  34. Comparative outcomes of IVIG versus corticosteroids in chronic inflammatory demyelinating polyneuropathy
  35. Efficacy of transcranial magnetic stimulation versus medication in managing treatment-resistant depression
  36. Comparative study on the effectiveness of IV versus oral corticosteroids in treating acute exacerbations of multiple sclerosis
  37. Evaluation of environmental risk factors in neuroinflammatory conditions like multiple sclerosis
  38. Role of genetic testing in early diagnosis of Charcot-Marie-Tooth disease
  39. Comparative effectiveness of levodopa versus dopamine agonists in early Parkinson’s disease
  40. Prospective analysis of environmental triggers and genetic susceptibility in migraine pathophysiology
  41. Impact of early intervention on long-term outcomes in pediatric-onset multiple sclerosis
  42. Comparative study of deep brain stimulation versus gamma knife surgery in essential tremor management
  43. Evaluation of serum biomarkers in predicting progression of amyotrophic lateral sclerosis
  44. Role of sleep-disordered breathing in cognitive impairment in Alzheimer’s patients
  45. Comparative study on CPAP therapy versus lifestyle modifications in treating mild obstructive sleep apnea
  46. Outcomes of cognitive behavioral therapy versus pharmacotherapy in managing insomnia in Parkinson’s disease
  47. Evaluation of risk factors and comorbidities in patients with REM sleep behavior disorder
  48. Comparative study on the efficacy of melatonin versus clonazepam in treating REM sleep behavior disorder
  49. Role of dopaminergic therapy in managing restless legs syndrome in end-stage renal disease
  50. Comparative analysis of cognitive outcomes in Parkinson’s disease patients on carbidopa-levodopa versus entacapone
  51. Prospective study on the impact of early physical therapy intervention in patients with newly diagnosed Parkinson’s disease
  52. Comparative effectiveness of botulinum toxin versus anticholinergics in managing dystonia
  53. Evaluation of risk factors for cognitive decline in patients with mild Parkinsonian symptoms
  54. Comparative outcomes of deep brain stimulation versus subthalamic stimulation in advanced Parkinson’s disease
  55. Efficacy of lifestyle modifications versus medication in managing early-stage Huntington’s disease
  56. Long-term outcomes of levodopa-carbidopa intestinal gel infusion in advanced Parkinson’s disease
  57. Comparative study of gabapentin versus pregabalin in treating neuropathic pain in diabetic patients
  58. Role of nerve growth factor inhibitors in the management of chemotherapy-induced neuropathy
  59. Outcomes of nerve transfer surgery versus conservative treatment in brachial plexus injury
  60. Comparative study on duloxetine versus amitriptyline in the treatment of postherpetic neuralgia
  61. Evaluation of spinal cord stimulation versus pharmacotherapy in managing chronic back pain
  62. Impact of physical rehabilitation versus pharmacologic treatment in managing post-stroke spasticity
  63. Comparative outcomes of minimally invasive surgery versus conservative management for trigeminal neuralgia
  64. Efficacy of multidisciplinary pain management versus standard care in chronic headache patients
  65. Prospective analysis of genetic risk factors for familial migraine
  66. Outcomes of manual therapy versus medication for management of chronic tension-type headaches
  67. Role of neuroimaging biomarkers in differentiating migraine from other primary headache disorders
  68. Comparative study of rituximab versus cyclophosphamide in neuromyelitis optica spectrum disorder
  69. Evaluation of long-term effects of natalizumab versus fingolimod in relapsing-remitting multiple sclerosis
  70. Efficacy of early disease-modifying therapy in reducing disability progression in pediatric MS
  71. Comparative study on ocrelizumab versus rituximab in progressive forms of multiple sclerosis
  72. Prospective study on serum biomarkers as predictors of relapse in neuromyelitis optica
  73. Outcomes of autologous hematopoietic stem cell transplantation in refractory multiple sclerosis
  74. Comparative effectiveness of immunosuppressive therapy versus plasmapheresis in acute multiple sclerosis relapse
  75. Role of cognitive rehabilitation in managing cognitive impairment in multiple sclerosis
  76. Evaluation of muscle strength and fatigue management in patients with Lambert-Eaton myasthenic syndrome
  77. Outcomes of repetitive nerve stimulation versus pharmacotherapy in treating myasthenia gravis
  78. Comparative effectiveness of plasmapheresis versus IVIG in acute exacerbations of myasthenia gravis
  79. Prospective study on long-term outcomes of thymectomy in young adults with myasthenia gravis
  80. Role of psychosocial support in improving quality of life in myasthenia gravis patients
  81. Comparative study on the use of corticosteroids versus immunosuppressants in managing myasthenic crisis
  82. Evaluation of transcranial magnetic stimulation versus cognitive behavioral therapy in chronic migraine patients
  83. Prospective study on the association between migraine and anxiety disorders
  84. Comparative study on treatment outcomes of patients with cluster headaches using galcanezumab versus standard care
  85. Role of lifestyle modifications in preventing migraine recurrence
  86. Comparative study on the efficacy of rimegepant versus ubrogepant in treating acute migraine attacks
  87. Evaluation of long-term outcomes in patients with refractory migraine treated with monoclonal antibodies
  88. Role of nerve blocks versus pharmacotherapy in refractory cluster headaches
  89. Comparative study of propanolol versus amitriptyline in migraine prophylaxis
  90. Prospective study on the relationship between sleep disorders and headache frequency in chronic migraine
  91. Role of exercise versus pharmacotherapy in reducing tension-type headache frequency
  92. Comparative outcomes of rituximab versus methotrexate in refractory multiple sclerosis
  93. Evaluation of brain atrophy as a predictor of disability in secondary-progressive multiple sclerosis
  94. Role of vitamin D supplementation in reducing relapse rates in multiple sclerosis
  95. Comparative study on patient-reported outcomes in relapsing versus primary progressive multiple sclerosis
  96. Efficacy of plasma exchange versus immunoadsorption in neuromyelitis optica spectrum disorder
  97. Comparative study on treatment outcomes of rituximab versus ocrelizumab in NMOSD
  98. Role of regular exercise in improving fatigue management in MS patients
  99. Evaluation of cognitive rehabilitation in enhancing memory function in MS patients
  100. Outcomes of corticosteroid therapy versus plasma exchange in acute demyelinating encephalomyelitis
  101. Comparative study on immunotherapy versus IVIG in treating pediatric Guillain-Barré syndrome
  102. Long-term outcomes of intravenous immunoglobulin versus corticosteroids in chronic inflammatory demyelinating polyneuropathy
  103. Role of genetic testing in early diagnosis and management of hereditary neuropathies
  104. Comparative study of lifestyle modification versus pharmacotherapy in managing neuropathic pain in diabetic patients
  105. Outcomes of botulinum toxin injections versus anticonvulsants in managing neuropathic pain
  106. Efficacy of cognitive behavioral therapy versus physical therapy in managing chronic low back pain
  107. Comparative study on the impact of deep brain stimulation versus medication in dystonia patients
  108. Prospective study on levodopa-induced dyskinesias in Parkinson’s disease patients
  109. Evaluation of exercise and lifestyle modification in improving motor symptoms in early Parkinson’s disease
  110. Role of genetic mutations in early-onset versus late-onset Alzheimer’s disease
  111. Comparative outcomes of donepezil versus memantine in early-stage Alzheimer’s disease
  112. Prospective analysis of amyloid-targeting therapies in patients with mild cognitive impairment
  113. Evaluation of risk factors for cognitive decline in patients with early Alzheimer’s disease
  114. Comparative outcomes of aerobic exercise versus strength training in mild cognitive impairment
  115. Prospective study on the role of brain-derived neurotrophic factor in Alzheimer’s disease
  116. Efficacy of acetylcholinesterase inhibitors versus NMDA antagonists in managing cognitive symptoms of dementia
  117. Long-term outcomes of early intervention with cholinesterase inhibitors in Alzheimer’s patients
  118. Comparative study on the efficacy of intranasal insulin versus placebo in early Alzheimer’s disease
  119. Role of genetic counseling in improving quality of life in families with Huntington’s disease
  120. Comparative outcomes of motor versus non-motor symptom management in Huntington’s disease
  121. Role of neuroimaging in early diagnosis of Huntington’s disease
  122. Evaluation of biomarkers in predicting progression in Parkinson’s disease
  123. Comparative study on outcomes of levodopa versus dopamine agonists in managing motor symptoms in early Parkinson’s disease
  124. Outcomes of continuous dopaminergic stimulation versus intermittent therapy in managing motor fluctuations
  125. Efficacy of deep brain stimulation versus medication in Parkinson’s disease patients with severe tremor
  126. Comparative study on outcomes of stem cell therapy versus gene therapy in managing neurodegenerative diseases
  127. Role of CRISPR gene editing in treating genetic neurological disorders
  128. Comparative outcomes of gene therapy versus enzyme replacement therapy in lysosomal storage diseases
  129. Evaluation of the role of serotonin receptors in managing aggression in Huntington’s disease
  130. Comparative study on transcranial direct current stimulation versus transcranial magnetic stimulation in depression associated with Parkinson’s disease
  131. Prospective study on the impact of vitamin B12 supplementation in managing peripheral neuropathy in elderly patients
  132. Comparative outcomes of mindfulness-based therapy versus pharmacotherapy in chronic pain
  133. Role of genetic screening in early diagnosis of familial amyotrophic lateral sclerosis
  134. Comparative study on the efficacy of riluzole versus edaravone in ALS patients
  135. Outcomes of intravenous immunoglobulin versus corticosteroids in treating Lambert-Eaton myasthenic syndrome
  136. Prospective study on pain management in amyotrophic lateral sclerosis using non-opioid analgesics
  137. Evaluation of cardiovascular complications in patients with neuromuscular diseases
  138. Comparative study on intrathecal baclofen versus oral antispasmodics in treating spasticity in ALS
  139. Role of gene therapy in the management of spinal muscular atrophy in pediatric patients
  140. Prospective study on impact of environmental factors on familial versus sporadic ALS
Premium Neurology Thesis Topics
international journal of medical case reports
medical publications
dental thesis topics

© 2024 SS Topics

© 2024 SS Topics

Don`t copy text!
×